Related by context. All words. (Click for frequent words.) 73 Statistically Significant 72 Lung Cancer Trial 72 Treated Patients 72 Efficacy Endpoints 71 Statin Therapy 71 Kidney Function 70 Improved Survival 70 Primary Endpoint 70 Elderly Patients 69 Rheumatoid Arthritis Patients 69 Fracture Risk 69 Pooled Analysis 69 Prostate Cancer Patients 69 Oral Fingolimod 69 Fungal Infections 69 Patients Receiving 68 Cholesterol Levels 68 Preterm Infants 68 Improves Survival 68 Demonstrates Efficacy 68 Lupus Drug 68 Study Showed 68 Metastatic Renal Cell Carcinoma 68 Prolongs Survival 68 Survival Benefit 68 Long Term Outcomes 68 Colorectal Cancer Patients 67 Knee Osteoarthritis 67 Lipid Levels 67 Insulin Glargine 67 Non Responders 67 Study Demonstrates 67 Appears Safe 67 Relapsing Multiple Sclerosis 67 Resistant Hypertension 67 Cognitive Impairment 67 Clinical Trial Results 67 Patients Suffering 67 Kidney Transplant Recipients 67 Statistical Significance 67 Venous Thromboembolism 67 Patients Treated 67 Non Inferiority 67 Demonstrated Significant 67 Neoadjuvant Chemotherapy 67 Clinical Trial Data 67 Radiation Dose 66 Reduced Risk 66 Blood Clot Risk 66 Antitumor Activity 66 Cardiovascular Disease Risk 66 Survival Rate 66 Gout Drug 66 Combination Treatment 66 Metastatic Prostate Cancer 66 Previously Treated 66 Showed Significant 66 Glycemic Control 66 Phase 2a Clinical Trial 66 Pediatric Patients 66 Adjuvant Chemotherapy 66 Phase III Trial 66 Single Dose 66 Postmenopausal Women 66 Is Well Tolerated 66 Breast Cancer Recurrence 66 Significantly Reduced 66 Clinical Outcome 66 Monotherapy 66 Insulin Sensitivity 66 Data Suggest 66 Patient Enrollment 66 Heart Failure Patients 66 Inhaled Corticosteroids 66 Phase IIb Clinical Trial 66 Significant Improvements 66 Platelet Inhibition 66 Unfractionated Heparin 66 Relapsing Remitting Multiple Sclerosis 65 Investigational Drug 65 Bone Mineral Density 65 Adjuvant Therapy 65 Phase IIb Trial 65 Epilepsy Drug 65 Hemoglobin Levels 65 Slow Progression 65 Investigational Agent 65 Renal Cell Carcinoma 65 Cardiovascular Events 65 Phase 2b Trial 65 Meets Primary Endpoint 65 Gene Variant 65 Blood Pressure Drug 65 Double Blind Randomized 65 Stent Placement 65 Septic Shock 65 Proven Effective 65 Blood Pressure Lowering 65 Aggressive Prostate Cancer 65 Anti Tumor Activity 65 Premature Infants 65 Shows Efficacy 65 Improves Outcomes 65 Mortality Risk 65 Obese Patients 65 Bare Metal Stents 65 Osteoporosis Drugs 65 Radiation Doses 65 Hormone Receptor Positive 65 Phase III Clinical Trial 65 Adjuvant Treatment 65 See CLINICAL PHARMACOLOGY 65 Calcium Intake 65 Cholesterol Lowering Drug 65 Minimally Invasive Treatment 65 Prostate Tumors 65 Surgical Procedures 65 Multiple Myeloma Patients 65 Prophylactic Treatment 65 Schizophrenia Treatment 65 Breast Tissue 65 Novel Inhibitor 65 Advanced Prostate Cancer 65 Placebo Controlled Study 65 Shows Promising 65 Levels Linked 65 Liver Failure 65 Critically Ill Patients 65 Newly Diagnosed Multiple Myeloma 64 Demonstrates Potent 64 Colorectal Cancer Risk 64 Proves Effective 64 Cardiovascular Outcomes 64 Orthostatic Hypotension 64 Randomized Clinical Trial 64 Plus Ribavirin 64 Phase III Trials 64 Invasive Breast Cancer 64 Significant Reduction 64 Beta Blocker 64 FDA Approvals 64 Patients Undergoing 64 Antibiotic Treatment 64 Demonstrate Significant 64 Stent Implantation 64 Contrast Agents 64 Adjunctive Therapy 64 Fewer Side Effects 64 Survival Rates 64 Lowers Risk 64 Randomized Trials 64 Partial Onset Seizures 64 Predict Risk 64 Advanced Melanoma 64 Clinically Tested 64 Antibiotic Use 64 Preclinical Data 64 Phase 2b Clinical Trial 64 Dementia Risk 64 HER2 Positive Breast Cancer 64 Anticancer Activity 64 Dose Escalation 64 Hip Fractures 64 Brain Metastases 64 Localized Prostate Cancer 64 Chronic Sinusitis 64 Obese Teens 64 Endothelial Function 64 Pivotal Phase III 64 Anti Tumor 64 Asthma Treatment 64 Improve Survival 64 Lung Function 64 Diabetic Patients 64 Long Term Efficacy 64 Carotid Endarterectomy 64 LDL Cholesterol 64 Genetic Mutations 64 Neuroprotective Effects 64 Study Evaluating 64 Tolerability 64 Patient Outcomes 64 Long Term Survival 64 Phase 2b Study 64 Versus Placebo 64 Genetic Variants 64 Inflammatory Markers 64 Lung Cancer Survival 64 Hyperlipidemia 64 Prostate Cancer Risk 64 Androgen Deprivation 64 Antiplatelet Therapy 64 Hypercholesterolemia 64 Beta Blockers 64 Prognostic Value 64 Immune Responses 64 Skin Lesions 64 Abdominal Pain 64 Panic Disorder 64 Platelet Aggregation 64 Phase 2a Trial 64 Blood Pressure Drugs 64 Antidepressant Use 64 Renal Function 64 Significantly Improved 64 Dose Ranging Study 64 Efficacious 64 Pharmacokinetic Study 64 Infected Patients 64 Patients Treated With 64 Skin Cancers 63 Cognitive Decline 63 Hepatitis C Treatment 63 Phase Ib Clinical Trial 63 Hospitalization Rates 63 Chronic Hepatitis B 63 Hepatitis C Patients 63 Ischemic Stroke 63 Gene Variants 63 Lymph Nodes 63 Treating Chronic 63 JAK Inhibitor 63 Diabetic Nephropathy 63 Stent Thrombosis 63 Estrogen Therapy 63 Patency 63 Cholesterol Drugs 63 Investigational Compound 63 Kidney Transplant Patients 63 Obesity Linked 63 Complete Remission 63 Symptom Relief 63 MRSA Infections 63 Main Outcome Measures 63 Unmet Medical 63 Phase III Pivotal Trial 63 Hematological Cancers 63 Inhaled Steroids 63 Follicular Lymphoma 63 Sleep Disturbances 63 Generalized Anxiety Disorder 63 Statin Drugs 63 Asthma Symptoms 63 Brain Atrophy 63 Low Density Lipoprotein Cholesterol 63 Severe Asthma 63 Prognostic Factors 63 Platelet Counts 63 Ovarian Cancer Risk 63 Demonstrates Positive 63 Beneficial Effects 63 Demonstrates Significant 63 Advanced Colorectal Cancer 63 Transplant Patients 63 Peginterferon Alfa 2a 63 Well Tolerated 63 Data Indicate 63 Clostridium difficile Infection 63 ACE Inhibitors 63 Nymox NX 63 Pivotal Study 63 Sinus Infections 63 Combo Therapy 63 Premenopausal Women 63 Carotid Stenting 63 Placebo Controlled Trial 63 Study Shows Significant 63 Confirmatory Phase 63 Depressive Symptoms 63 Drug Combo 63 Nicotine Vaccine 63 Hormone Refractory Prostate Cancer 62 First Patient Enrolled 62 Pivotal Phase 62 Gene Linked 62 Chemotherapeutic Agents 62 Tiotropium 62 Interferon Beta 62 Capsules CII 62 Suicidal Ideation 62 Antipsychotic Medications 62 Percent Reduction 62 Endovascular Treatment 62 Significantly Reduces 62 Epoetin Alfa 62 Limb Ischemia 62 Drug Prevents 62 Relapsed Multiple Myeloma 62 Randomized Controlled Trials 62 Significant Improvement 62 Valopicitabine NM# 62 Lower Blood Pressure 62 Antipsychotic Drug 62 Kidney Transplants 62 ER Visits 62 Partial Nephrectomy 62 Guidelines Issued 62 Novel Oral 62 Migraine Headaches 62 Hemodialysis Patients 62 Stent Restenosis 62 Treating Depression 62 Low Dose 62 Clot Risk 62 Cognitive Function 62 Multicenter Trial 62 Desvenlafaxine Succinate 62 Glucose Levels 62 Hormonal Therapy 62 Overactive Bladder 62 Metastatic Melanoma 62 Visceral Fat 62 Fibromyalgia Pain 62 Lymphoma Patients 62 Renal Cancer 62 Treatment Reduces 62 HDL Cholesterol 62 Metastatic Colorectal Cancer 62 Peginterferon 62 Subtypes 62 Calcium Supplements 62 Study Casts Doubt 62 Sirolimus Eluting Stent 62 Prostate Cancer Recurrence 62 Jobless Claims Jump 62 Physical Function 62 Artery Disease 62 Antiviral Drugs 62 Autologous Stem Cell Transplantation 62 Complication Rates 62 Allergic Rhinitis 62 Pulmonary Artery 62 Dendritic Cells 62 Eye Infections 62 Genetic Tests 62 Protease Inhibitor 62 Hypertensive Patients 62 Endometrial Cancer 62 Respiratory Distress 62 Reduces Pain 62 Testosterone Levels 62 Treatment Naive 62 Often Misdiagnosed 62 Diagnostic Criteria 62 Cause Mortality 62 Regimens 62 Endocrine Therapy 62 Peanut Allergies 62 Fat Cells 62 ST Segment Elevation 62 Bloodstream Infections 62 Drug Candidate 62 Clinical Trial Evaluating 62 Androgen Deprivation Therapy 62 FDA Okays 62 Medication Adherence 62 Osteoarthritis Pain 62 Randomized Study 62 Chemotherapy Improves 62 Drug Shows Promise 62 Abdominal Fat 62 Advanced Pancreatic Cancer 61 Antipsychotic Drugs 61 Significantly Improves 61 Commonly Used 61 Brain Shrinkage 61 Investigational Treatment 61 IND Application 61 Antiepileptic Drug 61 Radical Prostatectomy 61 Blood Vessels 61 Statin Use 61 Antiplatelet 61 Stress Levels 61 Study Shows Benefits 61 Treatment Naive Patients 61 Genes Predict 61 Blood Glucose Levels 61 Alternative Treatments 61 Recurrent Breast Cancer 61 Certain Cancers 61 Treatment Regimen 61 Pregnancy Linked 61 Respiratory Infections 61 Systolic Blood Pressure 61 Viral Load 61 Atypical Antipsychotics 61 Moderate Drinking 61 Tablet Formulation 61 Rheumatoid Arthritis Drug 61 Trial Evaluating 61 Subgroup Analysis 61 Osteoarthritis Patients 61 Infection Rate 61 Immunogenicity 61 Intracranial Aneurysms 61 Lung Cancer Risk 61 Reduces Risk 61 Glatiramer Acetate 61 Cardiac Function 61 Dose Ranging 61 Controlled Study 61 Teen Pregnancy Rates 61 Preclinical Study 61 Functional Outcomes 61 Opioid Use 61 Sustained Efficacy 61 Controlled Trial 61 Less Invasive 61 Pre Cancerous 61 Iron Deficiency 61 Anti Inflammatory Drug 61 PDUFA Date 61 Prostate Cancer Survival 61 Observational Studies 61 Breast Cancer Incidence 61 Cholinesterase Inhibitors 61 Gene Mutations 61 Liver Damage 61 Painkiller Abuse 61 Genes Linked 61 Advanced Ovarian Cancer 61 Therapy Reduces 61 Atopic Dermatitis 61 Increases Risk 61 Laryngeal Cancer 61 Drug Fails 61 Pivotal Trial 61 Breast Cancer Stem Cells 61 Benign Prostatic Hyperplasia 61 Genetic Markers 61 Dose Response 61 Proteinuria 61 Prognostic Significance 61 Salt Intake 61 Thrombotic 61 Adverse Event 61 Bivalirudin 61 Adefovir 61 Non Invasive Treatment 61 Genetic Mutation 61 Breast Density 61 Liver Transplants 61 Results Indicate 61 Disease Progression 61 Ejection Fraction 61 Skeletal Muscle 61 Breast Tumors 61 Deep Venous Thrombosis 61 Viral Suppression 61 Psoriasis Patients 61 Inhaled Nitric Oxide 61 Osteoporosis Treatment 61 Radiofrequency Ablation RFA 61 Castration Resistant Prostate Cancer 60 Randomized Controlled 60 Ovary Removal 60 Drug Reactions 60 Clinical Outcomes 60 Pivotal Trials 60 FDA Approves Drug 60 Carotid Artery Stenting 60 Vertebral Compression Fractures 60 Treatment Resistant 60 Protein Linked 60 Retention Rates 60 HCV Protease Inhibitor 60 PREZISTA r arm 60 Higher Doses 60 Lipid Lowering 60 Effectively Treats 60 Cinacalcet 60 Randomized Double Blind 60 Yr Ago 60 Spinal Manipulation 60 Clinical Evaluation 60 Antidepressants Linked 60 Lung Injury 60 Heart Failure Risk 60 Urinary Tract Infections 60 Newly Diagnosed Patients 60 COPD Exacerbations 60 Coronary Artery Calcium 60 Chronic Hepatitis C 60 Predictive Value 60 Uric Acid 60 Juvenile Idiopathic Arthritis 60 Antiviral Activity 60 II Clinical Trial 60 Receptor Agonist 60 Bone Metastases 60 Mortality Rates 60 Induces 60 Brain Scans 60 Balloon Angioplasty 60 HEART FAILURE 60 Correlation Between 60 Randomized Placebo Controlled Trial 60 Muscle Wasting 60 Antipsychotic 60 Dialysis Patients 60 Glucose Control 60 Genetic Defect 60 Sleep Duration 60 Severe Sepsis 60 Radiation Exposure 60 Pharmacologic Treatment 60 Pregnant Smokers 60 NDA Submission 60 Endovascular Repair 60 Blood Pressure Medication 60 Telbivudine 60 Ozone Levels 60 Chronic Insomnia 60 Combination REOLYSIN R 60 Vitamin D Linked 60 Contrast Agent 60 Gene Mutation 60 Cancer Stem Cells 60 Randomised Trial 60 Treatment Shows Promise 60 Comorbidities 60 Epileptic Seizures 60 Fondaparinux 60 Stress Incontinence 60 Preterm Delivery 60 Left Ventricular 60 Nebulized 60 Male Contraceptive 60 Diabetic Neuropathy 60 Initiates Clinical Trial 60 Stress Hormone 60 Malignant Glioma 60 Bladder Cancer Risk 60 Diabetic Foot Ulcers 60 Combination Clinical Trial 60 ADHD Medication 60 Signaling Pathways 60 Novel Method 60 Post Operative 60 Deepening Recession 60 Pulmonary Arterial Hypertension 60 Reveals Significant 60 Coronary Arteries 60 Prospective Randomized 60 Zoledronic Acid 60 Psoriasis Drug 60 Previously Untreated 60 Study Reinforces 60 Suicidality 60 Pancreatic Cancer Risk 60 Cystic 60 Phase III Clinical Trials 60 B Cell Lymphoma 60 Antibiotic Therapy 60 PPD Declares 60 Blepharospasm 60 Therapy Improves 60 Symptom Improvement 60 Meta Analysis 60 Blocked Arteries 60 Significant Reductions 60 Present Preclinical Data 60 Neoadjuvant 60 Oral Cavity 60 Gastrointestinal Stromal Tumors 60 Results Confirm 60 Birth Defect Risk 60 Phase IIa Clinical Trial 60 Liver Injury 60 Elevated Levels 60 Double Blind Placebo 60 Bone Marrow Cells 60 Peginterferon Alfa 2b 60 Ischemic 60 Percutaneous Tibial Nerve Stimulation 60 Sleep Disturbance 60 Sustained Virologic Response 60 Stroke Risk 60 Breast Carcinoma 60 Demonstrates Statistically Significant 60 C Reactive Protein 59 Lung Cancer Deaths 59 Autoimmune Disorders 59 Genes Associated 59 STRIDE PD 59 Tumor Growth 59 Ranolazine 59 Underscore Need 59 IND Filing 59 Novel Mechanism 59 Vitamin D Supplementation 59 Remains Flat 59 Gene Variation 59 Anticoagulant 59 Hormone Levels 59 Squamous Cell Carcinoma 59 Antitumor 59 Secondary Hyperparathyroidism 59 Radiofrequency Ablation 59 Transdermal Patch 59 Erosive Esophagitis 59 Cilostazol 59 Randomized Comparison 59 Naive Patients 59 Glucose Metabolism 59 Interferon Alfa 59 Restenosis 59 Adverse Outcomes 59 Jobless Claims Hit 59 Aromatase Inhibitors 59 Patient Enrolment 59 Stem Cell Transplants 59 Complicated Skin 59 Bone Fractures 59 Newly Identified 59 Hernia Repair 59 Periodontal Disease 59 Late Breaker 59 generalized edema 59 Aortic Stenosis 59 Insulin Levels 59 Molecular Mechanism 59 Severe Acne 59 Watchful Waiting 59 Organ Rejection 59 Medication Errors 59 Novel Compound 59 Orally Active 59 Reduce Expenses 59 Who Underwent 59 Combination Therapy 59 Premature Death 59 Chronic Renal Failure 59 Decitabine 59 Jobless Claims Drop 59 Short Stature 59 Vitamin D Supplements 59 Completes Patient Enrollment 59 Raw Material Prices 59 Helps Predict 59 First Patient Dosed 59 BioElectronics Announces 59 Mortality Rate 59 Heart Transplants 59 Wholesale Inventories Rise 59 Minimally Invasive Procedure 59 Hematologic 59 Oral Mucositis 59 Eye Diseases 59 Left Atrial 59 Pegylated Interferon 59 Allogeneic 59 Brain Function 59 Heel Pain 59 Liver Toxicity 59 Acute Coronary Syndromes 59 Significant Milestones 59 Adenomas 59 Risedronate 59 Vitamin D Levels 59 Chemotherapy Induced 59 Fatty Liver 59 Aortic Aneurysms 59 MGS Futures Untraded 59 Pharmacodynamics 59 Completes Enrollment 59 Kidney Disease Patients 59 Cardiotoxicity 59 Lifestyle Intervention 59 Inflammatory Response 59 Premature Births 59 Insulin Secretion 59 Menopausal Women 59 Oral Anticoagulant 59 Vildagliptin 59 Lower Limb 59 Immunomedics Announces 59 Retreatment 59 Growth Trajectory 59 Jobless Claims Dip 59 Drug Regimen 59 Non Alcoholic Steatohepatitis 59 Virus Infection 59 Postprandial 59 Randomized Phase 59 Lowering Blood Pressure 59 Diagnostic Tests 59 Metastatic Pancreatic Cancer 59 Solid Tumors 59 Acute Ischemic Stroke 59 Ascites 59 Extended Release Formulation 59 Kinase Inhibitor 58 Fixed Dose 58 Pregnancy Outcomes 58 Help Predict 58 Relapsed Refractory 58 Dual Antiplatelet Therapy 58 Enoxaparin 58 Urinary Catheter 58 Meningococcal Disease 58 Chronic Stress 58 Jobless Claims Fall 58 Nilotinib 58 Nonalcoholic Fatty Liver Disease 58 FDA Clears 58 Prostate Biopsy 58 Digestive Tract 58 Invasive Fungal Infections 58 Jobless Claims Unexpectedly 58 Eur J 58 Refractory Hodgkin Lymphoma 58 Adverse Effects 58 Differential Diagnosis 58 CLINICAL PHARMACOLOGY 58 Predict Prostate Cancer 58 Gestational Diabetes 58 Hepatocellular Carcinoma 58 Mental Health Disorders 58 Immunomodulatory 58 Eye Exams 58 Shows Promise Against 58 KLIBOR Futures 58 Efficacy Trial 58 Crowflight Announces 58 Potent Antiviral Activity 58 Overweight Obese 58 Darbepoetin Alfa 58 Successfully Completes Phase 58 Thrombus 58 Hepatitis C Genotype 58 Bone Marrow Transplants 58 Radiation Induced 58 Cash Balances 58 Unresectable 58 Progenitor Cells 58 Sleep Patterns 58 Obesity Rates 58 Increased Risk 58 Dyslipidemia 58 Carboplatin Paclitaxel 58 Measles Cases 58 Flu Deaths 58 Outcome Measures 58 Imaging Techniques 58 Genetic Variation 58 Migraine Sufferers 58 Cervical Spine 58 Renal Insufficiency 58 Angiographic 58 Hepatic Encephalopathy 58 Cardiovascular Risk Reduction 58 Spinal Fractures 58 Poniard Pharmaceuticals Announces 58 Soybeans Grains 58 Calorie Intake 58 Extended Release 58 Thromboembolic 58 Test Detects 58 Lung Tumors 58 Respiratory Syncytial Virus 58 Presents Positive 58 Ear Infections 58 Arch Facial Plast 58 Universal Flu Vaccine 58 Stenosis 58 Dietary Intake 58 KEMET Announces 58 Parathyroid Hormone 58 Confirms Efficacy 58 INCB# [003] 58 Seasonal Allergies 58 Staph Infections 58 Clinical Efficacy 58 Early Diagnosis 58 Receives Orphan Drug Designation 58 Strongly Linked 58 Aggressive Reduction 58 Severe Alzheimer Disease 58 Chronic Bronchitis 58 Diuretic 58 Acne Scars 58 Mycophenolate Mofetil 58 Generic Versions 58 Cardiac Arrest Patients 58 Recurrent Ovarian Cancer 58 Tyrosine Kinase Inhibitor 58 Antibiotic Resistant 58 Cerebrospinal Fluid 58 Topical Cream 58 Vertebral Fracture 58 Cyclophosphamide 58 Abnormality 58 Content Outline 58 Randomized Clinical Trials 58 KLCI Futures 58 Randomized Phase III 58 Pt Chg 58 Trend Toward 58 Prove Effective 58 Effective Treatments 58 Breathing Problems 58 Genotypes 58 Antidepressant Treatment 58 Could Predict 58 Urine Test 58 GRAS Status 58 Dementia Patients 58 Sodium Intake 58 Drug Eluting Stents 58 Dose Reduction 58 ARIXTRA R 58 Intraocular Pressure 58 Oral Formulation 58 Respiratory Illness 58 Illicit Drug Use 58 Anti TNF 58 Blood Cholesterol 58 Patient Deaths 58 Inhibits 58 Predict Breast Cancer 58 Reduces Mortality 57 Thyroid Function 57 Stress Induced 57 Renal Tumors 57 Neoplasms 57 Milestone Payment 57 Preterm Births 57 Bioavailability 57 Natalizumab 57 Antiangiogenic 57 Tumor Cells 57 Study Indicates 57 Hsp# Inhibitor 57 Technological Advances 57 Blood Glucose 57 Infarct 57 Partial Seizures 57 Abciximab 57 Prolongs Life 57 Demonstrates Sustained 57 Symptom Score 57 Recombinant Human 57 HIV Infections 57 NMDA Receptor 57 Respiratory Symptoms 57 Fluticasone Propionate 57 Helps Relieve 57 Potent Anti 57 Stomatitis 57 Placebo Controlled 57 Intra Arterial 57 Spectrum Pharmaceuticals Announces 57 Causing Bacteria 57 Cardiac Resynchronization 57 Am Soc Nephrol 57 Yen Crosses 57 Hip Fracture Risk 57 Angioedema 57 ST Elevation Myocardial 57 See WARNINGS 57 #/#-Year Low 57 Cognitive Problems 57 Varies Widely 57 BIOLASE Announces 57 Product Types 57 Acute Myocardial Infarction 57 Guideline Update 57 Treatment Outcomes 57 Resubmission 57 Hematological 57 Kidney Tumors 57 Larger Than Expected 57 Treatment Outcome 57 Premature Deaths 57 Electrical Stimulation 57 Bronchodilator 57 Asthma Attacks 57 Helps Identify 57 Diabetes Epidemic 57 Imaging Technique 57 Obese Kids 57 ViaSat Receives 57 Initiate Phase 57 Could Prevent 57 Heart Transplant Recipients 57 Findings Reveal 57 Hepatotoxicity 57 Help Detect 57 Gender Differences 57 Hypotension 57 Tigecycline 57 Drug Resistant Bacteria 57 FOR WELL BEING 57 Versus Loonie 57 Capacity FVC 57 Improving Patient Safety 57 Physician Shortage 57 Postoperative Ileus 57 Amount Spent 57 Prostate Cancer Screening 57 Cognitive Dysfunction 57 Microalbuminuria 57 Swine Flu Vaccines 57 Pesticide Exposure 57 Presents Preclinical Data 57 lopinavir r arm 57 CO Poisoning 57 Hemoglobin A1c 57 SGOT 57 Platinol ® 57 Regulatory Requirements 57 Decompensated Heart Failure 57 Prices Remain 57 Substantially Reduce 57 Oil Tumbles 57 Slower Rate 57 Improves Quality 57 Various Types 57 HCV Genotype 57 Immunosuppression 57 Pract 57 Prostate Cancer Diagnosis 57 nausea somnolence 57 Prostate Cancer Progression 57 First Trimester 57 Colorectal Screening 57 Underlie 57 Their Respective 57 Cyclooxygenase 2 57 Virtual Colonoscopy 57 Fulvestrant 57 Flu Vaccinations 57 Catheter Ablation 57 Excellon Announces 57 Invasive Procedures 57 Consumer Confidence Jumps 57 Socioeconomic Status 57 Dramatically Reduced 57 Resistant Bacteria 57 Myocardial Ischemia 57 Childhood Vaccinations 57 Medoxomil 57 Aurora Kinase 57 Atypical Antipsychotic 57 Can Predict 57 unfractionated heparin UFH 57 Teaching Positions 57 Rapidly Increasing 57 HCV Infection 57 Improve Accuracy 57 Tumor Response 57 Protein Synthesis 57 BioSante Pharmaceuticals Reports 57 Syphilis Cases 57 Protease Inhibitors 57 Postherpetic Neuralgia 57 ISTODAX ® 57 PRN FDA Approves 57 Magnetic Stimulation 57 Risk Stratification 57 Steady Decline 57 Cardiogenic Shock 56 Bacterial Infections 56 Treatment Naive HIV 56 Childhood Cancers 56 TLUS 56 Solid Tumor 56 Tuberculosis Cases 56 Tipranavir 56 Hemolysis 56 Potency 56 Asthma Inhaler 56 Nosocomial 56 Structural Changes 56 Reduce Risk 56 Suicidal Thoughts 56 Breast Exams 56 Monthly Dividends 56 Whooping Cough Vaccine 56 Antiviral Therapy 56 Renal Impairment 56 Potentially Deadly 56 Jobless Claims Increase 56 oxycodone CR 56 FOREX Ringgit Likely 56 Sirolimus Eluting 56 Slight Improvement 56 Otitis Media 56 Key Attributes 56 Prophylaxis 56 Shows Statistically Significant 56 FOLPI 56 Knee Replacements 56 Phase 2a Study 56 Miscarriage Risk 56 Could Save Lives 56 Mortgage Rates Fall